ArticleMolecules (Basel, Switzerland)2024
Visible-Light-Induced Photocatalytic Degradation of Naproxen Using 5% Cu/TiO
Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lignin-Based Cationic Hydrogels Incorporating MIL-100(Fe) for Combined Adsorption and Photo-Fenton Degradation of Naproxen Sodium.ACS applied engineering materials · 2026Article
- Titanium dioxide nanoparticles as a sustainable solution for soil and water polluted with naphthalene and phenanthrene.Open veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The presence of drugs in wastewater effluent is of concern due to their effects on the aquatic fauna and flora and there are growing efforts for their removal from the environment. In this paper, we study the photocatalytic visible-light degradation of naproxen, an over-the-counter anti-inflammatory drug, using 5% copper-doped TiO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.